ART NR.: A300-589A (100 µl)
Anwendungen: WB, IP
Format: antigen affinity purified
Reaktivität: human, mouse
Immunogen: synthetic peptide. The epitope recognized by A300-589A maps to a region between residue 750 and the C-terminus (residue 806) of human Valosin-Containing Protein using the numbering given in entry NP_009057.1 (GeneID 7415).
UniProt ID: P55072
Suche mit UniProt ID
Schlagworte: Anti-VCP, Anti-Valosin-Containing Protein, Anti-TERA, Anti-Transitional Endoplasmic Reticulum ATPase, Anti-p97, Anti-IBMPFD, Anti-Inclusion Body Myopathy associated with Paget Disease of Bone and Frontotemporal Dementia.
Valosin-containing protein (VCP) is a multifunctional protein that is proposed to be involved in vesicle transport and fusion for protein trafficking, 26S proteasome function in ubiquitin-based degradation pathways, and the assembly of peroxisomes. Mutations in the human VCP gene have been associated with diseases such as inclusion body myopathy, Paget disease of the bone, and frontotemporal dementia (IBMPFD). VCP can inhibit apoptosis and may play a role in tumorigenesis. VCP is also known as, Transitional Endoplasmic Reticulum ATPase, TER ATPase, TERA, 15S Mg (2plus)-ATPase p97subunit, IBMPFD, Inclusion Body Myopathy associated with Paget Disease of Bone and Frontotemporal Dementia, MGC8560, MGC131997, MGC148092.
Products for: VCP, CDC48 - transitional endoplasmic reticulum ATPase